Dergiler / Balkan Medical Journal / 2020 / Cilt: 37 - Sayı: 3

Neonatal Thrombocytopenia and the Role of the Platelet Mass Index in Platelet Transfusion in the Neonatal Intensive Care Unit

Sayfa
150–156
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The medical records of neonatesin the neonatal intensive care unit with platelet counts

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background: Neonatal thrombocytopenia is a common hematologicalabnormality that occurs in 20–35% of all newborns in the neonatalintensive care unit.
📊
Temel Bulgular & Veri:Platelet transfusion is the only known treatment;however, it is the critical point to identify neonates who are really atrisk of bleeding and benefit from platelet transfusion as it also hasvarious potential harmful effects.Aims: To investigate the prevalence and risk factors of neonatalthrombocytopenia and its relationship to intraventricular hemorrhagein the neonatal intensive care unit and to determine whether the useof platelet mass index-based criteria could reduce the rate of platelettransfusion.Study Design: Retrospective cohort study.Methods: This study was conducted in the neonatal intensive careunit of a tertiary university hospital.
💡
Sonuç & Katkı:The medical records of neonatesin the neonatal intensive care unit with platelet counts
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background: Neonatal thrombocytopenia is a common hematologicalabnormality that occurs in 20–35% of all newborns in the neonatalintensive care unit. Platelet transfusion is the only known treatment;however, it is the critical point to identify neonates who are really atrisk of bleeding and benefit from platelet transfusion as it also hasvarious potential harmful effects.Aims: To investigate the prevalence and risk factors of neonatalthrombocytopenia and its relationship to intraventricular hemorrhagein the neonatal intensive care unit and to determine whether the useof platelet mass index-based criteria could reduce the rate of platelettransfusion.Study Design: Retrospective cohort study.Methods: This study was conducted in the neonatal intensive careunit of a tertiary university hospital. The medical records of neonatesin the neonatal intensive care unit with platelet counts

🔖

Bu Makaleye Atıf Yap

GÜL, A., TAKÇI, Ş., SÖNMEZGÖZ, E., GÜMÜŞER, R., DEMİR, O., KASAP, T., IRAK, B. E., COŞKUN, U. S. Ş. (2022). Neonatal Thrombocytopenia and the Role of the Platelet Mass Index in Platelet Transfusion in the Neonatal Intensive Care Unit. Balkan Medical Journal, Cilt: 37 - Sayı: 3, 150–156. https://ajindex.com/articles/460862

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Roberts I, Stanworth S, Murray NA. Thrombocytopenia in the neonate. Blood Rev 2008;22:173-86
  2. Sola-Visner M, Sallmon H, Brown R. New insights into the mechanisms of nonimmune thrombocytopenia in neonates. Semin Perinatol 2009;33:43-51
  3. Kenton AB, Hegemier S, Smith EO, O'Donovan DJ, Brandt ML, Cass DL, et al. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity. J Perinatol 2005;25:173-7
  4. Kopko PM, Holland PV. Mechanisms of severe transfusion reactions. Transfus Clin Biol 2001;8:278-81
  5. Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfusion Med Rev 2003;17:120-62
  6. Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost 2015;114:449-58
  7. Curley A, Stanworth SJ, Willoughby K, Fustolo-Gunnink SF, Venkatesh V, Hudson C, et al. Randomized Trial of Platelet-Transfusion Thresholds in Neonates. N Engl J Med 2019;380:242-51
  8. Cremer M, Sola-Visner M, Roll S, Josephson CD, Yilmaz Z, Bührer C, et al. Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion 2011;51:2634-41
  9. Gerday E, Baer VL, Lambert DK, Paul DA, Sola-Visner MC, Pysher TJ, et al. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit. Transfusion 2009;49:2034-9
  10. Christensen RD, Paul DA, Sola-Visner MC, Baer VL. Improving platelet transfusion practices in the neonatal intensive care unit. Transfusion 2008;48:2281-4
  11. Kahvecioglu D, Erdeve O, Alan S, Cakir U, Yildiz D, Atasay B, et al. The impact of evaluating platelet transfusion need by platelet mass index on reducing the unnecessary transfusions in newborns. J Matern Fetal Neonatal Med 2014;27:1787-9
  12. Zisk JL, Mackley A, Clearly G, Chang E, Christensen RD, Paul DA. Transfusing neonates based on platelet count vs. platelet mass: a randomized feasibility-pilot study. Platelets 2014;25:513-6
  13. Yavuzcan Öztürk D, Erçin S, Gürsoy T, Karatekin G, Ovalı F. Platelet mass index: is it a hope for reduction of platelet transfusion in NICU? J Matern Fetal Neonatal Med 2016;29:1926-9
  14. Sherlock RL, Anderson PJ, Doyle LW; Victorian Infant Collaborative Study Group. Neurodevelopmental sequelae of intraventricular haemorrhage at 8 years of age in a regional cohort of ELBW/very preterm infants. Early Hum Dev 2005;81:909-16
  15. Bassan H, Limp